article thumbnail

Should Big Companies Give Up on Innovation?

Harvard Business Review

It’s a common question thrown at me by entrepreneurs, venture capitalists, or the more cynically minded corporate leaders. That is, why bother trying to innovate if no matter what they do, large companies can no longer maintain a sustainable advantage and their life spans are just getting shorter and shorter? “Why bother?”.

article thumbnail

Precision Medicine Could Have a Major Impact on Healthcare Outcomes and Costs - SPONSOR CONTENT FROM SIEMENS HEALTHINEERS

Harvard Business Review

The transformation of health care continues at a rapid pace, bringing opportunities and challenges for health care providers to deliver improved clinical outcomes at lower costs. And many health care systems continue to struggle to reliably deliver evidence-based care.

Cost 8
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Planting Entrepreneurial Innovation in Inner Cities

Harvard Business Review

Today, inner cities are "in" — innovative, hip hotbeds of convenient culture, commerce and connection. The centripetal force of today's cities is pulling the ambitious and educated back in, and increasing cities' innovative capacity, without sacrificing (at least some would argue) their inclusiveness.

article thumbnail

Reversing the Decline in Big Ideas

Harvard Business Review

Many venture capitalists are up in the arms because their returns are down, their funds are drying up, and there appear to be a declining number of entrepreneurs pursuing big ideas. Unfortunately, venture capitalists have mixed up their causality. Have all the innovative ideas already been done? What gives?

article thumbnail

Reversing the Decline in Big Ideas

Harvard Business Review

Many venture capitalists are up in the arms because their returns are down, their funds are drying up, and there appear to be a declining number of entrepreneurs pursuing big ideas. Unfortunately, venture capitalists have mixed up their causality. Have all the innovative ideas already been done? What gives?

article thumbnail

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

Change and innovation are choices, not givens, in any organization, and there are managerial levers for making these selections wisely. Within EB, Merck first created a Global Health Innovation Fund and then a Healthcare Services and Solution unit to identify, develop, and operate nascent opportunities that fit that thesis.

article thumbnail

For Some Platforms, Network Effects Are No Match for Local Know-How

Harvard Business Review

To venture capitalists and the financial market, no business model is more attractive than a platform. As more sectors embrace a digital strategy — transportation, aviation, health care, energy, and so on — managers will find that a deep understanding of their market is still the most potent defense against competition.